Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 17603-42-8
2. 1,2,3-propanetriol, 1-(dihydrogen Phosphate), Sodium Salt
3. Sodium;2,3-dihydroxypropyl Hydrogen Phosphate
4. Sodium Alpha Glycerophosphate
5. Einecs 241-577-0
6. Alpha-natrium Glycerophosphat [german]
7. Alpha-natrium Glycerophosphat
8. 2,3-dihydroxypropyl (dihydrogen Phosphate), Sodium Salt
9. Disodium,1,3-dihydroxypropan-2-yl Phosphate,hydrate
10. Glycerol, 1-(dihydrogen Phosphate), Sodium Salt
11. Sodiumglycerophosphate
12. Sodium Alpha-glycerophosphate
13. 1,2,3-propentriol, 1-(dihydrogen Phosphate), Sodium Salt
14. Dtxsid70938740
15. Einecs 254-713-9
16. Akos006346295
17. Ft-0696352
18. A913951
19. 1,2,3-propanetriol, Mono(dihydrogen Phosphate), Sodium Salt
20. 1,2,3-propanetriol, 1-(dihydrogen Phosphate), Sodium Salt (1:?)
| Molecular Weight | 194.06 g/mol |
|---|---|
| Molecular Formula | C3H8NaO6P |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 193.99561925 g/mol |
| Monoisotopic Mass | 193.99561925 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 140 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)
USFDA APPLICATION NUMBER - 200656
Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
92
PharmaCompass offers a list of Sodium Glycerophosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier.
PharmaCompass also assists you with knowing the Sodium Glycerophosphate API Price utilized in the formulation of products. Sodium Glycerophosphate API Price is not always fixed or binding as the Sodium Glycerophosphate Price is obtained through a variety of data sources. The Sodium Glycerophosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A alpha-glycerophosphoric acid, sodium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of alpha-glycerophosphoric acid, sodium salt, including repackagers and relabelers. The FDA regulates alpha-glycerophosphoric acid, sodium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. alpha-glycerophosphoric acid, sodium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of alpha-glycerophosphoric acid, sodium salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A alpha-glycerophosphoric acid, sodium salt supplier is an individual or a company that provides alpha-glycerophosphoric acid, sodium salt active pharmaceutical ingredient (API) or alpha-glycerophosphoric acid, sodium salt finished formulations upon request. The alpha-glycerophosphoric acid, sodium salt suppliers may include alpha-glycerophosphoric acid, sodium salt API manufacturers, exporters, distributors and traders.
click here to find a list of alpha-glycerophosphoric acid, sodium salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A alpha-glycerophosphoric acid, sodium salt DMF (Drug Master File) is a document detailing the whole manufacturing process of alpha-glycerophosphoric acid, sodium salt active pharmaceutical ingredient (API) in detail. Different forms of alpha-glycerophosphoric acid, sodium salt DMFs exist exist since differing nations have different regulations, such as alpha-glycerophosphoric acid, sodium salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A alpha-glycerophosphoric acid, sodium salt DMF submitted to regulatory agencies in the US is known as a USDMF. alpha-glycerophosphoric acid, sodium salt USDMF includes data on alpha-glycerophosphoric acid, sodium salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The alpha-glycerophosphoric acid, sodium salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of alpha-glycerophosphoric acid, sodium salt suppliers with USDMF on PharmaCompass.
A alpha-glycerophosphoric acid, sodium salt CEP of the European Pharmacopoeia monograph is often referred to as a alpha-glycerophosphoric acid, sodium salt Certificate of Suitability (COS). The purpose of a alpha-glycerophosphoric acid, sodium salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of alpha-glycerophosphoric acid, sodium salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of alpha-glycerophosphoric acid, sodium salt to their clients by showing that a alpha-glycerophosphoric acid, sodium salt CEP has been issued for it. The manufacturer submits a alpha-glycerophosphoric acid, sodium salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a alpha-glycerophosphoric acid, sodium salt CEP holder for the record. Additionally, the data presented in the alpha-glycerophosphoric acid, sodium salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the alpha-glycerophosphoric acid, sodium salt DMF.
A alpha-glycerophosphoric acid, sodium salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. alpha-glycerophosphoric acid, sodium salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of alpha-glycerophosphoric acid, sodium salt suppliers with CEP (COS) on PharmaCompass.
A alpha-glycerophosphoric acid, sodium salt written confirmation (alpha-glycerophosphoric acid, sodium salt WC) is an official document issued by a regulatory agency to a alpha-glycerophosphoric acid, sodium salt manufacturer, verifying that the manufacturing facility of a alpha-glycerophosphoric acid, sodium salt active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting alpha-glycerophosphoric acid, sodium salt APIs or alpha-glycerophosphoric acid, sodium salt finished pharmaceutical products to another nation, regulatory agencies frequently require a alpha-glycerophosphoric acid, sodium salt WC (written confirmation) as part of the regulatory process.
click here to find a list of alpha-glycerophosphoric acid, sodium salt suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing alpha-glycerophosphoric acid, sodium salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for alpha-glycerophosphoric acid, sodium salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture alpha-glycerophosphoric acid, sodium salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain alpha-glycerophosphoric acid, sodium salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a alpha-glycerophosphoric acid, sodium salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of alpha-glycerophosphoric acid, sodium salt suppliers with NDC on PharmaCompass.
alpha-glycerophosphoric acid, sodium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of alpha-glycerophosphoric acid, sodium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right alpha-glycerophosphoric acid, sodium salt GMP manufacturer or alpha-glycerophosphoric acid, sodium salt GMP API supplier for your needs.
A alpha-glycerophosphoric acid, sodium salt CoA (Certificate of Analysis) is a formal document that attests to alpha-glycerophosphoric acid, sodium salt's compliance with alpha-glycerophosphoric acid, sodium salt specifications and serves as a tool for batch-level quality control.
alpha-glycerophosphoric acid, sodium salt CoA mostly includes findings from lab analyses of a specific batch. For each alpha-glycerophosphoric acid, sodium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
alpha-glycerophosphoric acid, sodium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (alpha-glycerophosphoric acid, sodium salt EP), alpha-glycerophosphoric acid, sodium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (alpha-glycerophosphoric acid, sodium salt USP).
